SE7909392L - Nya substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner - Google Patents
Nya substituerade 5-(2-imidazolin-2-yl)-aminopyrimidinerInfo
- Publication number
- SE7909392L SE7909392L SE7909392A SE7909392A SE7909392L SE 7909392 L SE7909392 L SE 7909392L SE 7909392 A SE7909392 A SE 7909392A SE 7909392 A SE7909392 A SE 7909392A SE 7909392 L SE7909392 L SE 7909392L
- Authority
- SE
- Sweden
- Prior art keywords
- aminopyrimidines
- imidazolin
- hydrogen
- carbon atoms
- present
- Prior art date
Links
- 150000005005 aminopyrimidines Chemical class 0.000 title abstract 2
- -1 2-IMIDAZOLIN-2-YL Chemical class 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2849537A DE2849537C2 (de) | 1978-11-15 | 1978-11-15 | Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
DE19792937023 DE2937023A1 (de) | 1979-09-13 | 1979-09-13 | Neue substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7909392L true SE7909392L (sv) | 1980-05-16 |
SE440079B SE440079B (sv) | 1985-07-15 |
Family
ID=25776489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7909392A SE440079B (sv) | 1978-11-15 | 1979-11-14 | Substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner och farmaceutisk komposition |
Country Status (12)
Country | Link |
---|---|
US (1) | US4323570A (sv) |
AT (1) | AT374197B (sv) |
AU (1) | AU541305B1 (sv) |
CA (1) | CA1138454A (sv) |
CH (1) | CH642965A5 (sv) |
DK (1) | DK150142C (sv) |
ES (1) | ES486349A1 (sv) |
FR (1) | FR2441625A1 (sv) |
GB (1) | GB2039275B (sv) |
IT (1) | IT1127225B (sv) |
NL (2) | NL190553C (sv) |
SE (1) | SE440079B (sv) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2146986B (en) * | 1983-09-23 | 1987-06-17 | Lilly Co Eli | Process for preparing 5-substituted pyrimidines |
DE3729299A1 (de) * | 1987-09-02 | 1989-03-23 | Beiersdorf Ag | Transdermales therapeutisches system |
DE3739779A1 (de) * | 1987-11-24 | 1989-06-08 | Beiersdorf Ag | Pharmazeutische praeparate |
DE3904795C2 (de) * | 1989-02-17 | 2000-10-12 | Lilly Pharma Produktion Gmbh & | Pharmazeutisches Präparat und dessen Verwendung |
US5972948A (en) * | 1994-07-01 | 1999-10-26 | Solvay Pharmaceuticals Gmbh | Method of inhibiting hyperglycemia and pharmaceutical composition for use therein |
DE4423177A1 (de) * | 1994-07-01 | 1996-01-04 | Kali Chemie Pharma Gmbh | Antihyperglykämisch wirksame Arzneimittel |
AU4941796A (en) * | 1995-02-28 | 1996-09-18 | Beiersdorf-Lilly Gmbh | Use of moxonidine for the treatment of atherosclerosis |
DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
IL118544A (en) * | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
CA2182851A1 (en) * | 1995-08-15 | 1997-02-16 | August Masaru Watanabe | Method for treating substance abuse withdrawal |
ZA974978B (en) * | 1996-06-06 | 1998-12-07 | Lilly Co Eli | Formulation and method for treating congestive heart failure |
ZA981029B (en) * | 1997-02-11 | 1999-08-10 | Lilly Co Eli | Pharmaceutical agents. |
DE19722322A1 (de) * | 1997-05-28 | 1998-12-03 | Solvay Pharm Gmbh | Nephroprotektives Arzneimittel |
AU9302298A (en) * | 1997-09-03 | 1999-03-22 | Eli Lilly And Company | Pyrimidine derivatives |
DE19911371A1 (de) | 1999-03-15 | 2000-09-21 | Solvay Pharm Gmbh | Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen |
EP1517688A2 (de) * | 2002-06-19 | 2005-03-30 | Solvay Pharmaceuticals GmbH | Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen |
BRPI0707308A2 (pt) * | 2006-01-27 | 2011-05-03 | Hoffmann La Roche | uso de 2-imidazóis para o tratamento de distúrbios do snc |
ATE411310T1 (de) * | 2006-06-26 | 2008-10-15 | Chemagis Ltd | Reinigungsverfahren von moxonidine |
EP1894926A1 (en) * | 2006-06-26 | 2008-03-05 | Chemagis Ltd. | Polymorphs of moxonidine and processes for preparation therefor |
ES2369113T3 (es) | 2006-06-26 | 2011-11-25 | Chemagis Ltd. | Procedimiento mejorado para producir moxonidina. |
EP2054391A4 (en) * | 2006-08-17 | 2009-08-26 | Chemagis Ltd | A SINGLE TAUTOMER-CONTAINING CRYSTALLINE MOXONIDINE AND METHOD FOR THE PRODUCTION THEREOF |
DE602006018139D1 (de) * | 2006-08-31 | 2010-12-23 | Chemagis Ltd | Verwendung der Monoxidinssalze zur Reinigung von Monoxidin |
CA2665255A1 (en) * | 2006-10-19 | 2008-04-24 | F. Hoffmann-La Roche Ag | Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
BRPI0717939A2 (pt) * | 2006-10-19 | 2013-12-03 | Hoffmann La Roche | Aminometil-4-imidazóis |
BRPI0718054A2 (pt) * | 2006-11-02 | 2013-11-05 | Hoffmann La Roche | 2-imidazóis substituídos como moduladores de receptores associados à traços de aminas |
JP2010510184A (ja) * | 2006-11-16 | 2010-04-02 | エフ.ホフマン−ラ ロシュ アーゲー | 置換4−イミダゾール類 |
WO2008073125A1 (en) * | 2006-12-12 | 2008-06-19 | Chemagis Ltd. | Moxonidine analogs, preparation processes and uses therefor |
BRPI0720047A2 (pt) * | 2006-12-13 | 2013-12-24 | Hoffmann La Roche | 2-imidazóis como ligantes para receptores associados a aminas de traço (taar) |
US20080146523A1 (en) * | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
RU2473545C2 (ru) * | 2007-02-02 | 2013-01-27 | Ф.Хоффманн-Ля Рош Аг | Новые 2-аминооксазолины в качестве лигандов taar1 для заболеваний цнс |
KR101222412B1 (ko) * | 2007-02-15 | 2013-01-15 | 에프. 호프만-라 로슈 아게 | Taar1 리간드로서의 2-아미노옥사졸린 |
CA2691082A1 (en) | 2007-07-02 | 2009-01-08 | F. Hoffmann-La Roche Ag | 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
WO2009003867A1 (en) * | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
AU2008281918A1 (en) * | 2007-07-27 | 2009-02-05 | F. Hoffmann-La Roche Ag | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands |
JP2010535172A (ja) * | 2007-08-02 | 2010-11-18 | エフ.ホフマン−ラ ロシュ アーゲー | Cns障害の処置のためのベンズアミド誘導体の使用 |
CA2695331A1 (en) * | 2007-08-03 | 2009-02-12 | F. Hoffmann-La Roche Ag | Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
JP5547187B2 (ja) * | 2008-07-24 | 2014-07-09 | エフ.ホフマン−ラ ロシュ アーゲー | 4,5−ジヒドロ−オキサゾール−2−イル誘導体 |
US20100311798A1 (en) * | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
US8354441B2 (en) * | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
EP2586779A1 (en) | 2011-10-24 | 2013-05-01 | Hetero Research Foundation | Process for the preparation of moxonidine |
DE102012215896A1 (de) * | 2012-09-07 | 2014-03-13 | Wörwag Pharma GmbH & Co.KG | Moxonidinsynthese mit Hilfe organischer Basen |
EP2738165B1 (en) | 2012-12-03 | 2016-10-12 | WÖRWAG PHARMA GmbH & Co. KG | Method by means of phase transfer catalysis |
EP2765131B1 (en) | 2013-02-08 | 2016-11-23 | Arevipharma GmbH | Process for the production of Moxonidine |
CN105121431A (zh) * | 2013-03-14 | 2015-12-02 | 法尔马克有限公司 | 用于制造莫索尼定的改进方法 |
EP2829540A1 (en) | 2013-07-26 | 2015-01-28 | Abbott Healthcare Products B.V. | Synthesis of substituted aminopyridines |
JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス,インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
SG11201807516UA (en) | 2016-03-17 | 2018-09-27 | Hoffmann La Roche | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar |
WO2022101435A1 (en) | 2020-11-12 | 2022-05-19 | 3Z Ehf | Novel treatments of attention deficit/hyperactivity disorder |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE754832A (fr) | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | Iminazolines |
GB1319840A (en) * | 1970-08-27 | 1973-06-13 | Beecham Group Ltd | Substituted 5-amino imidazoles |
BE795636A (fr) * | 1972-02-19 | 1973-08-20 | Schering Ag | Nitroimidazolylpyrimidines, et leur procede de preparation |
US4029792A (en) * | 1972-02-29 | 1977-06-14 | Pfizer Inc. | (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents |
DE2220906A1 (de) * | 1972-04-28 | 1973-11-15 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung |
BE503170A (sv) * | 1975-09-02 |
-
1979
- 1979-11-07 US US06/092,134 patent/US4323570A/en not_active Expired - Lifetime
- 1979-11-08 NL NLAANVRAGE7908192,A patent/NL190553C/xx not_active IP Right Cessation
- 1979-11-14 IT IT27284/79A patent/IT1127225B/it active
- 1979-11-14 AT AT0727079A patent/AT374197B/de not_active IP Right Cessation
- 1979-11-14 CA CA000339844A patent/CA1138454A/en not_active Expired
- 1979-11-14 ES ES486349A patent/ES486349A1/es not_active Expired
- 1979-11-14 DK DK481879A patent/DK150142C/da not_active IP Right Cessation
- 1979-11-14 SE SE7909392A patent/SE440079B/sv not_active IP Right Cessation
- 1979-11-14 GB GB7939460A patent/GB2039275B/en not_active Expired
- 1979-11-15 FR FR7928169A patent/FR2441625A1/fr active Granted
- 1979-11-15 CH CH1021679A patent/CH642965A5/de not_active IP Right Cessation
- 1979-11-15 AU AU52873/79A patent/AU541305B1/en not_active Expired
-
1994
- 1994-06-27 NL NL940011C patent/NL940011I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
ES486349A1 (es) | 1980-06-16 |
DK481879A (da) | 1980-05-16 |
FR2441625A1 (fr) | 1980-06-13 |
DK150142B (da) | 1986-12-15 |
ATA727079A (de) | 1983-08-15 |
CH642965A5 (de) | 1984-05-15 |
GB2039275B (en) | 1982-11-17 |
NL940011I1 (nl) | 1994-08-01 |
NL940011I2 (nl) | 1998-05-06 |
GB2039275A (en) | 1980-08-06 |
DK150142C (da) | 1987-06-01 |
US4323570A (en) | 1982-04-06 |
FR2441625B1 (sv) | 1981-12-31 |
NL7908192A (nl) | 1980-05-19 |
AU541305B1 (en) | 1985-01-03 |
IT1127225B (it) | 1986-05-21 |
IT7927284A0 (it) | 1979-11-14 |
NL190553B (nl) | 1993-11-16 |
CA1138454A (en) | 1982-12-28 |
AT374197B (de) | 1984-03-26 |
SE440079B (sv) | 1985-07-15 |
NL190553C (nl) | 1994-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7909392L (sv) | Nya substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner | |
SE7906722L (sv) | Merkaptoacylderivat av substituerade proliner | |
ATE24001T1 (de) | Substituierte 1-hydroxyethyl-triazolyl-derivate. | |
IT1171880B (it) | Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione | |
FI880494A (fi) | Nya 5-alkoxi-2,4-diaminoalkylbenzener samt dessa innehaollande haorfaergningsmedel. | |
ATE18768T1 (de) | Neue 6-alpha-methylprednisolon-derivate ihre herstellung und verwendung. | |
PT91575A (pt) | Procede de preparation de benzylamines disubstituees utiles comme medicaments | |
ES2022993B3 (es) | Nuevos esteres de acidos ciclopropanocarboxilicos emparentados al acido piretrico, procedimiento de preparacion y aplicacion en la lucha contra los parasitos | |
ZA816259B (en) | 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants | |
ATE97899T1 (de) | 1,8-benzonaphthyridinderivate, ihre herstellung und diese enthaltende zusammensetzungen. | |
ZA889023B (en) | 2-(piperazinyl)-2-oxoethylene substituted flavonoid derivatives,processes for preparing them and pharmaceutical compositions containing them | |
IT1196423B (it) | Benzotiazolin-composti | |
SE8502525L (sv) | 1,3-oxazolidin-2-on-derivat och forfaranden for framstellning derav | |
ATE76405T1 (de) | 2-trifluormethyl-benzimidazole. | |
FI843354A (fi) | Foerfarande foer framstaellning av nya 4-fenyl-4-oxo-2-ensmoersyraderivat. | |
ATE13885T1 (de) | Phenylpiperazinderivate von hetarylphenolen und hetarylanilinen, ihre herstellung und diese enthaltende therapeutische mittel. | |
DK384485D0 (da) | 1,6-naphthyridinderivater med kardilaterende virkning | |
DK0452926T3 (da) | 5-Aryl-4-alkyl-3H-1,2,4-triazol-3-thioner, der kan anvendes som hukommelsesforbedrende midler | |
FI803654L (fi) | Nya substituerade 2-fenylaminoimidazoliner-(2) deras syraadditionssalter dessa foereningar innehaollande laekemedel och deras framstaellningsfoerfarande | |
ATE16384T1 (de) | Phenylpiperazinyl-propanole von hetarylphenolen, ihre herstellung und diese enthaltende therapeutische mittel. | |
ES542393A0 (es) | "4-(nitrofenil)-tetrahidropiridinas,procedimiento para su obtencion y su empleo como medicamento" | |
NO822828L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1-fenylindazol-3-on-forbindelser og deres salter | |
ATE144900T1 (de) | Verwendung von xanthinderivaten gegen magengeschwüre | |
ATE98961T1 (de) | 1,8-benzonaphthyridinderivate und ihre herstellung. | |
NO159380C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive amidazolderivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7909392-8 |
|
SPCF | Application for supplementary protection certificate filed |
Free format text: 9990012, 981023 |
|
SPCG | Supplementary protection certificate granted |
Free format text: 9990012, 981023, EXPIRES: 20041114 |
|
NUG | Patent has lapsed |
Ref document number: 7909392-8 |